As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
July 30, 2024 — Patients with congestive heart failure (CHF) having a compromised blood supply, are at greater risk of ...
July 29, 2024 — When it comes to treating cardiac arrest, acting quickly can mean the difference between life and death ...
July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...
July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...
July 12, 2024 — Researchers have developed a groundbreaking method for analyzing heart MRI scans with the help of artifi ...
July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...
July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...
From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June:
1. Med ...
July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...
June 27, 2024 — The human body has sophisticated defenses against the deposition of calcium minerals that stiffen heart ...
June 27, 2024 — Cardiovascular disease is the leading cause of death for women, and gaps in care and access persist ...
June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...
June 24, 2024 — Endotronix, Inc., a privately held company dedicated to advancing the treatment of heart failure (HF) at ...
June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...
July 30, 2024